A kind of limulus peptide-antibody fusion protein and its preparation method
A technology of fusion protein and limulus peptide, applied in the direction of anti-animal/human immunoglobulin, anti-receptor/cell surface antigen/cell surface determinant immunoglobulin, chemical instruments and methods, etc., can solve the problem of antibacterial activity and other issues to achieve the effect of low toxic and side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0133] A method for preparing a limulus peptide-antibody fusion protein, using genetic engineering methods to modify the limulus peptide gene at the genetic level, and linking the limulus peptide gene T to the coding antibody unit directly or through the linking peptide gene LU encoding the linker unit The 3' end or the 5' end of the heavy or light chain of the gene M, forming (T-LU) N –M method, construct recombinant expression plasmid, express its fusion protein through host cell,
[0134] The preparation method comprises steps as follows:
[0135] (1) Using genetic engineering methods to connect the limulus peptide gene through the linker gene or directly to the antibody gene, and connect it to the expression vector to obtain a recombinant expression plasmid, the specific steps are as follows:
[0136] ①Using overlap extension PCR technology, using the anti-CD19Fab L chain with the sequence SQ20 as the template, through two PCRs, the G 4 The S gene, the T1 gene and the st...
Embodiment 1
[0163] 1. Obtain the light chain variable region gene (VL) and heavy chain variable region (VH) gene of anti-CD19 antibody:
[0164] The sequences of the light chain variable region gene (VL) and the heavy chain variable region (VH) gene of the anti-CD19 antibody are from the patent: Anti-CD19 engineering antibody for targeting lymphocytic leukemia cells and its use (publication number CN 1775808A).
[0165] The light chain variable region (VL) gene of the anti-CD19 antibody, that is, the nucleic acid sequence of anti-CD19VL is SQ24.
[0166] The heavy chain variable region (VH) gene of the anti-CD19 antibody, that is, the nucleic acid sequence of anti-CD19VH is SQ25.
[0167] The above two gene sequences were obtained by synthetic methods. At the same time, in order to facilitate the construction of the expression vector and the connection of the variable region and the constant region, a restriction site Mlu I and a protective base were introduced at the 5' end of the VL ge...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com